Physician profile
Keith E Brown
NPI 1114923166
$2,595.11
in general payments reported to CMS, 2019-2025
10 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $907 · 2023: $378 · 2024: $187 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,199 · Food and Beverage: $468 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,199.23 |
| Food and Beverage | $468.39 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,082.81 | 2024-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Abiomed | $1,037.47 | 2022-2023 | Impella |
| Abbott Laboratories | $251.66 | 2022-2024 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $52.90 | 2024-2025 | |
| Si-Bone, INC. | $52.26 | 2024 | |
| Collegium Pharmaceutical, INC. | $41.28 | 2023-2025 | Belbuca |
| Painteq LLC | $22.08 | 2024 | Painteq |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Globus Medical, INC. | $19.91 | 2025 | Senza |
| Nevro Corp. | $14.74 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.